Creative Planning’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$540K Buy
4,749
+503
+12% +$57.2K ﹤0.01% 2402
2025
Q1
$446K Buy
4,246
+1,012
+31% +$106K ﹤0.01% 2376
2024
Q4
$347K Buy
3,234
+338
+12% +$36.2K ﹤0.01% 2535
2024
Q3
$290K Buy
2,896
+111
+4% +$11.1K ﹤0.01% 2544
2024
Q2
$235K Buy
+2,785
New +$235K ﹤0.01% 2544
2020
Q1
Sell
-15,541
Closed -$1.01M 1844
2019
Q4
$1.01M Sell
15,541
-18
-0.1% -$1.17K ﹤0.01% 779
2019
Q3
$966K Sell
15,559
-697
-4% -$43.3K ﹤0.01% 773
2019
Q2
$1.16M Sell
16,256
-55
-0.3% -$3.92K ﹤0.01% 702
2019
Q1
$1.28M Buy
16,311
+1,020
+7% +$80K ﹤0.01% 625
2018
Q4
$1.29M Sell
15,291
-2,978
-16% -$252K 0.01% 560
2018
Q3
$3.13M Buy
18,269
+1,211
+7% +$207K 0.01% 373
2018
Q2
$2.2M Buy
17,058
+2,015
+13% +$260K 0.01% 438
2018
Q1
$1.55M Sell
15,043
-158
-1% -$16.3K 0.01% 529
2017
Q4
$1.3M Sell
15,201
-310
-2% -$26.5K 0.01% 588
2017
Q3
$1.32M Buy
15,511
+483
+3% +$41K 0.01% 593
2017
Q2
$1.14M Sell
15,028
-306
-2% -$23.2K 0.01% 623
2017
Q1
$1.01M Buy
15,334
+83
+0.5% +$5.48K 0.01% 664
2016
Q4
$967K Buy
15,251
+19
+0.1% +$1.21K 0.01% 635
2016
Q3
$970K Sell
15,232
-1,117
-7% -$71.1K 0.01% 602
2016
Q2
$1.22M Buy
16,349
+335
+2% +$24.9K 0.01% 460
2016
Q1
$1.07M Buy
16,014
+1,273
+9% +$85.1K 0.01% 481
2015
Q4
$997K Sell
14,741
-80
-0.5% -$5.41K 0.01% 508
2015
Q3
$792K Buy
+14,821
New +$792K 0.01% 555
2015
Q2
Sell
-14,523
Closed -$699K 2061
2015
Q1
$699K Buy
14,523
+1,959
+16% +$94.3K 0.01% 598
2014
Q4
$417K Buy
12,564
+378
+3% +$12.5K ﹤0.01% 763
2014
Q3
$357K Buy
12,186
+801
+7% +$23.5K ﹤0.01% 787
2014
Q2
$442K Sell
11,385
-96
-0.8% -$3.73K 0.01% 688
2014
Q1
$482K Buy
11,481
+11,082
+2,777% +$465K 0.01% 633
2013
Q4
$13K Buy
399
+320
+405% +$10.4K ﹤0.01% 2423
2013
Q3
$2K Sell
79
-320
-80% -$8.1K ﹤0.01% 2986
2013
Q2
$9K Buy
+399
New +$9K ﹤0.01% 2323